Founded in 2013 by former New York City Deputy Mayor and CEO of Sidewalk Labs, Dan Doctoroff with support from Bloomberg Philanthropies, Target ALS is a non-profit foundation focused on fostering collaboration to accelerate ALS drug discovery and development. 

Non Profit

Target ALS

Target ALS' headquarters in New York City, United States

Manish Raisinghani

Jessica Chapman

Carole Ho

Richard Hargreaves

Andy Berndt

Tracy Saxton

Zaven Kaprielian

Rob Scannevin

Michael Ahlijanian

Kimberly Scearce - Levie

Kenneth Devaney

The Leadership Team at Target ALS is responsible for setting the strategic vision, guiding the overall direction, and ensuring seamless operations to accelerate ALS drug discovery and development. This team of experts oversees grant distribution, advances translational and clinical research, fosters collaborations, and steers the foundation's scientific and medical policies to drive innovation and progress in ALS treatment.

Leadership Team

The Research and Development Team at Target ALS is dedicated to advancing innovative drug discovery and development for Amyotrophic Lateral Sclerosis (ALS). This team collaborates across scientific disciplines, focusing on translational science, clinical neuroimaging, precision medicine, and cutting-edge research in neuroscience and rare diseases, to progress towards effective treatments and a cure for ALS.

Target ALS

Org chart

Teams

Leadership Team

Research and Development Team

Offices

Target ALS

Org chart

Teams

Leadership Team

Research and Development Team

Offices

Related companies